The DOI matches its Crossref record; 46 of the 47 references it cites were found in a registry or an index.
CD47 Is an Adverse Prognostic Factor and Therapeutic Antibody Target on Human Acute Myeloid Leukemia Stem Cells
Open accessAbstract
Acute myeloid leukemia (AML) is organized as a cellular hierarchy initiated and maintained by a subset of self-renewing leukemia stem cells (LSC). We hypothesized that increased CD47 expression on human AML LSC contributes to pathogenesis by inhibiting their phagocytosis through the interaction of CD47 with an inhibitory receptor on phagocytes. We found that CD47 was more highly expressed on AML LSC than their normal counterparts, and that increased CD47 expression predicted worse overall survival in three independent cohorts of adult AML patients. Furthermore, blocking monoclonal antibodies directed against CD47 preferentially enabled phagocytosis of AML LSC and inhibited their engraftment in vivo. Finally, treatment of human AML LSC-engrafted mice with anti-CD47 antibody depleted AML and targeted AML LSC. In summary, increased CD47 expression is an independent, poor prognostic factor that can be targeted on human AML stem cells with blocking monoclonal antibodies capable of enabling phagocytosis of LSC.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“increased CD47 levels on the surface of malignant cells correlate with dismal prognosis in subjects with AML, esophageal carcinoma, and ovarian cancer [888–891].”
From Molecular mechanisms of cell death: recommendations of the nomenclature committee on cell death 2018. (2018) · cites this paper as [891]
Citations
Cites
Stem cells, cancer, and cancer stem cells
Reya, T., Morrison, S. J., Clarke, M. F., & Weissman, I. L. (2001) · Nature · doi:10.1038/35102167 · Cited by 9,738
Self-citationBonnet, D. A., & Dick, J. E. (1997) · Nature Medicine · doi:10.1038/nm0797-730 · Cited by 7,197
Grimwade, D. J., Walker, H., Oliver, F., Wheatley, K., Harrison, C. J., Harrison, G., Rees, J., Hann, I. M., Stevens, R., Burnett, A. K., et al. (1998) · Blood · doi:10.1182/blood.v92.7.2322 · Cited by 2,649
Role of CD47 as a Marker of Self on Red Blood Cells
Oldenborg, P., Zheleznyak, A., Fang, Y., Lagenaur, C. F., Gresham, H. D., & Lindberg, F. P. (2000) · Science · doi:10.1126/science.288.5473.2051 · Cited by 2,018
Jordan, C. T., Guzmán, M. L., & Noble, M. (2006) · New England Journal of Medicine · doi:10.1056/nejmra061808 · Cited by 1,748
Mutations and Treatment Outcome in Cytogenetically Normal Acute Myeloid Leukemia
Schlenk, R. F., Döhner, K., Krauter, J., Fröhling, S., Corbacioglu, A., Bullinger, L., Habdank, M., Späth, D., Morgan, M., Benner, A., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa074306 · Cited by 1,628
Byrd, J. C. (2002) · Blood · doi:10.1182/blood-2002-03-0772 · Cited by 1,594
CD47 Is Upregulated on Circulating Hematopoietic Stem Cells and Leukemia Cells to Avoid Phagocytosis
Jaiswal, S., Jamieson, C. H. M., Pang, W. W., Park, C. Y., Chao, M. P., Majeti, R., Traver, D. J., van Rooijen, N., & Weissman, I. L. (2009) · Cell · doi:10.1016/j.cell.2009.05.046 · Cited by 1,578
Self-citationGranulocyte-macrophage progenitors as candidate leukemic stem cells in blast-crisis CML
Jamieson, C. H. M., Ailles, L. E., Dylla, S. J., Muijtjens, M., Jones, C., Zehnder, J. L., Gotlib, J., Li, K., Manz, M. G., Keating, A., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040258 · Cited by 1,485 · cited 2×
“Consistent with this hypothesis, we have shown that pre-leukemic mutations occur in a clonal HSC population, eventually leading to the development of LSC at the MPP stage in AML or the granulocyte-macrophage progenitor (GMP) stage in myeloid blast crisis chronic myeloid leukemia (CML) (Jamieson et al., 2004; Miyamoto…”
BackgroundSelf-citationBmi-1 determines the proliferative capacity of normal and leukaemic stem cells.
Lessard, J., & Sauvageau, G. (2003) · Nature · doi:10.1038/nature01572 · Cited by 1,452
Prognostically Useful Gene-Expression Profiles in Acute Myeloid Leukemia
Valk, P. J. M., Verhaak, R. G. W., Beijen, M. A., Erpelinck, C. A. J., van Doorn-Khosrovani, S. B. V. W., Boer, J. M., Beverloo, H. B., Moorhouse, M. J., van der Spek, P. J., Löwenberg, B., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040465 · Cited by 1,370
Estey, E. H., & Döhner, H. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69780-8 · Cited by 1,332
Löwenberg, B., Downing, J. R., & Burnett, A. K. (1999) · New England Journal of Medicine · doi:10.1056/nejm199909303411407 · Cited by 1,283
Monoclonal antibody therapy of cancer
Adams, G. P., & Weiner, L. M. (2005) · Nature Biotechnology · doi:10.1038/nbt1137 · Cited by 1,272
Targeting of CD44 eradicates human acute myeloid leukemic stem cells
Jin, L., Hope, K. J., Zhai, Q., Smadja‐Joffe, F., & Dick, J. E. (2006) · Nature Medicine · doi:10.1038/nm1483 · Cited by 1,247
Integrin-associated protein (CD47) and its ligands
Brown, E. (2001) · Trends in Cell Biology · doi:10.1016/s0962-8924(00)01906-1 · Cited by 880
Jordan, C. T., Upchurch, D., Szilvassy, S. J., Guzmán, M. L., Howard, D. S., Pettigrew, A. L., Meyerrose, T. E., Rossi, R., Grimes, B. A., Da, R., et al. (2000) · Leukemia · doi:10.1038/sj.leu.2401903 · Cited by 823
Identification of a Hierarchy of Multipotent Hematopoietic Progenitors in Human Cord Blood
Majeti, R., Park, C. Y., & Weissman, I. L. (2007) · Cell stem cell · doi:10.1016/j.stem.2007.10.001 · Cited by 657
Self-citationCancer stem cells: lessons from leukemia
Wang, J. C. Y., & Dick, J. E. (2005) · Trends in Cell Biology · doi:10.1016/j.tcb.2005.07.004 · Cited by 629
Mrózek, K., Marcucci, G., Paschka, P., Whitman, S. P., & Bloomfield, C. D. (2006) · Blood · doi:10.1182/blood-2006-06-001149 · Cited by 554
Jin, L., Lee, E. M., Ramshaw, H. S., Busfield, S. J., Peoppl, A. G., Wilkinson, L. J., Guthridge, M. A., Thomas, D., Barry, E. F., Boyd, A., et al. (2009) · Cell stem cell · doi:10.1016/j.stem.2009.04.018 · Cited by 530
Polymorphism in Sirpa modulates engraftment of human hematopoietic stem cells
Takenaka, K., Prasolava, T. K., Wang, J. C. Y., Mortin-Toth, S. M., Khalouei, S., Gan, O. I., Dick, J. E., & Danska, J. S. (2007) · Nature Immunology · doi:10.1038/ni1527 · Cited by 515
Miyamoto, T., Weissman, I. L., & Akashi, K. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.13.7521 · Cited by 465
Self-citationCd47-Signal Regulatory Protein α (Sirpα) Regulates Fcγ and Complement Receptor–Mediated Phagocytosis
Oldenborg, P., Gresham, H. D., & Lindberg, F. P. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.193.7.855 · Cited by 461
van Rhenen, A., van Dongen, G. A. M. S., Kelder, A., Rombouts, E. J. C., Feller, N., Moshaver, B., van Walsum, M., Zweegman, S., Ossenkoppele, G. J., & Schuurhuis, G. J. (2007) · Blood · doi:10.1182/blood-2007-03-083048 · Cited by 456
Metzeler, K. H., Hummel, M., Bloomfield, C. D., Spiekermann, K., Braess, J., Sauerland, M., Heinecke, A., Radmacher, M. D., Marcucci, G., Whitman, S. P., et al. (2008) · Blood · doi:10.1182/blood-2008-02-134411 · Cited by 443
The SIRP family of receptors and immune regulation
Barclay, A. N., & Brown, M. H. (2006) · Nature reviews. Immunology · doi:10.1038/nri1859 · Cited by 427
MicroRNA expression profiling in relation to the genetic heterogeneity of acute myeloid leukemia
Jongen‐Lavrencic, M., Sun, S. M., Dijkstra, M. K., Valk, P. J. M., & Löwenberg, B. (2008) · Blood · doi:10.1182/blood-2008-01-133355 · Cited by 406
CD96 is a leukemic stem cell-specific marker in human acute myeloid leukemia
Hosen, N., Park, C. Y., Tatsumi, N., Oji, Y., Sugiyama, H., Gramatzki, M., Krensky, A. M., & Weissman, I. L. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0704271104 · Cited by 393
Self-citationSeiffert, M., Cant, C., Chen, Z., Rappold, I., Brugger, W., Kanz, L., Brown, E. J., Ullrich, A., & Bühring, H. (1999) · Blood · doi:10.1182/blood.v94.11.3633 · Cited by 305
Role for CD47-SIRPα signaling in xenograft rejection by macrophages
Ide, K., Wang, H., Tahara, H., Liu, J., Wang, X., Asahara, T., Sykes, M., Yang, Y.-G., & Ohdan, H. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0609661104 · Cited by 304
Negative Regulation of Phagocytosis in Macrophages by the CD47-SHPS-1 System
Okazawa, H., Motegi, S., Ohyama, N., Ohnishi, H., Tomizawa, T., Kaneko, Y., Oldenborg, P., Ishikawa, O., & Matozaki, T. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.4.2004 · Cited by 303
Dysregulated gene expression networks in human acute myelogenous leukemia stem cells
Majeti, R., Becker, M. W., Tian, Q., Lee, T.-L. M., Yan, X., Liu, R., Chiang, J.-H., Hood, L., Clarke, M. F., & Weissman, I. L. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0900089106 · Cited by 281
Self-citationAntibodies, Fc receptors and cancer
Nimmerjahn, F., & Ravetch, J. V. (2007) · Current Opinion in Immunology · doi:10.1016/j.coi.2007.01.005 · Cited by 241
CD47 ligation induces caspase-independent cell death in chronic lymphocytic leukemia
Mateo, V., Lagneaux, L., Bron, D., Biron, G., Armant, M. A., Delespesse, G., & Sarfati, M. (1999) · Nature Medicine · doi:10.1038/15233 · Cited by 241
Latour, S., Tanaka, H., Demeure, C. E., Mateo, V., Rubio, M., Brown, E. J., Maliszewski, C. R., Lindberg, F. P., Oldenborg, A., Ullrich, A., et al. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.5.2547 · Cited by 238
Blazar, B. R., Lindberg, F. P., Ingulli, E. G., Panoskaltsis‐Mortari, A., Oldenborg, P., Iizuka, K., Yokoyama, W. M., & Taylor, P. A. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.194.4.541 · Cited by 205
Species- and cell type-specific interactions between CD47 and human SIRPα
Subramanian, S., Parthasarathy, R., Sen, S., Boder, E. T., & Discher, D. E. (2005) · Blood · doi:10.1182/blood-2005-04-1463 · Cited by 156
Weissman, I. L. (2005) · JAMA · doi:10.1001/jama.294.11.1359 · Cited by 150
Self-citationAn FLT3 gene-expression signature predicts clinical outcome in normal karyotype AML
Bullinger, L., Döhner, K., Kranz, R., Stirner, C., Fröhling, S., Scholl, C., Kim, Y. H., Schlenk, R. F., Tibshirani, R. J., Döhner, H., et al. (2008) · Blood · doi:10.1182/blood-2007-09-115055 · Cited by 99
Ailles, L., Gerhard, B., & Hogge, D. E. (1997) · Blood · doi:10.1182/blood.v90.7.2555 · Cited by 99
CD47 in the Immune Response: Role of Thrombospondin and SIRP-α Reverse Signaling
Sarfati, M., Fortin, G., Raymond, M., & Susín, S. A. (2008) · Current Drug Targets · doi:10.2174/138945008785909310 · Cited by 81
Kikuchi, Y., Uno, S., Kinoshita, Y., Yoshimura, Y., Iida, S.-I., Wakahara, Y., Tsuchiya, M., Yamada‐Okabe, H., & Fukushima, N. (2004) · Leukemia Research · doi:10.1016/j.leukres.2004.09.005 · Cited by 72
Antitumor activity of a monoclonal antibody against CD47 in xenograft models of human leukemia
Uno, S., Kinoshita, Y., Azuma, Y., Tsunenari, T., Yoshimura, Y., Iida, S., Kikuchi, Y., Yamada‐Okabe, H., & Fukushima, N. (2007) · Oncology Reports · doi:10.3892/or.17.5.1189 · Cited by 56
A bivalent single-chain Fv fragment against CD47 induces apoptosis for leukemic cells
Kikuchi, Y., Uno, S., Yoshimura, Y., Otabe, K., Iida, S.-I., Oh‐eda, M., Fukushima, N., & Tsuchiya, M. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.01.128 · Cited by 48
Braun, D., Galibert, L., Nakajima, T., Saito, H., Van, V. Q., Rubio, M., & Sarfati, M. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.12.8550 · Cited by 36
Flagged first, then by citations
1 of the 47 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Galluzzi, L., Vitale, I., Aaronson, S. A., Abrams, J. M., Adam, D., Agostinis, P., Alnemri, E. S., Altucci, L., Amelio, I., Andrews, D. W., et al. (2018) · Cell Death & Differentiation · doi:10.1038/s41418-017-0012-4 · Cited by 6,680
Tumour-associated macrophages as treatment targets in oncology
Mantovani, A., Marchesi, F., Malesci, A., Laghi, L., & Allavena, P. (2017) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2016.217 · Cited by 4,182
Immunogenic cell death in cancer and infectious disease
Galluzzi, L., Buqué, A., Kepp, O., Zitvogel, L., & Kroemer, G. (2017) · Nature Reviews Immunology · doi:10.1038/nri.2016.107 · Cited by 3,119
Macrophages in immunoregulation and therapeutics
Chen, S., Saeed, A. F. U. H., Liu, Q., Jiang, Q., Xu, H., Xiao, G. G., Rao, L., & Duo, Y. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01452-1 · Cited by 2,477
Evolution of the Cancer Stem Cell Model
Kreso, A., & Dick, J. E. (2014) · Cell stem cell · doi:10.1016/j.stem.2014.02.006 · Cited by 2,304
Metadata
- Authors
- Majeti, R., Chao, M. P., Alizadeh, A. A., Pang, W. W., Jaiswal, S., Gibbs, K. D., van Rooijen, N., & Weissman, I. L.
- Affiliations
- Stanford Medicine (US)
- Institute for Stem Cell Biology and Regenerative Medicine (US)
- Stanford University (US)
- Corresponding author
- Majeti, Ravindra
- Weissman, Irving L.
- ORCID
- Venue
- Cell
- Publisher
- Elsevier BV
- Published
- 2009-07
- Volume
- 138
- Issue
- 2
- Pages
- 286-299
- ISSN
- 0092-8674 (ISSN-L)
- PMC
- PMC2726837
- OpenAlex
- W2097126393
- Cited by
- 1,752
- References
- 47
- Citations by year
- 2026: 73 · 2025: 143 · 2024: 149 · 2023: 183 · 2022: 147 · 2021: 163 · 2020: 142 · 2019: 106 · 2018: 86 · 2017: 108 · 2016: 78 · 2015: 85 · 2014: 61 · 2013: 65 · 2012: 67
- FWCI
- 22.72
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- www.elsevier.com/open-access/userlicense/1.0/ (vor, 1477 d)
- doi.org/10.15223/policy-017 (stm-asf)
- doi.org/10.15223/policy-037 (stm-asf)
- doi.org/10.15223/policy-012 (stm-asf)
- doi.org/10.15223/policy-029 (stm-asf)
- doi.org/10.15223/policy-004 (stm-asf)
- Locations
- Cell (publishedVersion)
- PubMed (publishedVersion)
- Pure Amsterdam UMC (publishedVersion)
- Amsterdam UMC (VU Amsterdam) - Institutional Repository (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Digital Academic REpository of VU University Amsterdam (Vrije Universiteit Amsterdam) (submittedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Funders
- Howard Hughes Medical Institute
- National Cancer Institute (R01 CA86017, R01CA086017, T32CA009302)
- National Institute of Allergy and Infectious Diseases (T32AI007290)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Phagocytosis and Immune Regulation
- Health Sciences › Medicine › Hematology › Acute Myeloid Leukemia Research
- Health Sciences › Medicine › Pharmacology (medical) › Flavonoids in Medical Research
- Keywords
- CD47, acute myeloid leukemia, leukemia stem cells, prognostic factors, anti-CD47 monoclonal antibody, phagocytosis, overall survival, engraftment, targeted therapy
- MeSH terms
- Animals, Antibodies, Monoclonal, Humans, Phagocytosis, Prognosis, Receptors, Immunologic, Leukemia, Myeloid, Acute, Mice, CD47 Antigen
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
